Neurogene (NGNE) Exchange Rate Effect (2015 - 2020)
Neurogene (NGNE) reported Exchange Rate Effect of $14000.0 for Q2 2020, up 366.67% on a YoY basis from $3000.0 in Q3 2019, and up 227.27% quarter-over-quarter from -$11000.0 in Q1 2020.
Neurogene (NGNE) Exchange Rate Effect (2015 - 2020) Analysis & Trends
Neurogene has reported Exchange Rate Effect for 6 years, with the latest figure at $14000.0 in Q2 2020.
- For the quarter ending Q2 2020, Exchange Rate Effect rose 366.67% year-over-year to $14000.0; the trailing twelve-month figure through Jun 2021 stood at $3000.0 (down 72.73% YoY), and the FY2019 full-year result was $10000.0, up 120.83% from the prior year.
- Exchange Rate Effect for Q2 2020 stood at $14000.0, up from -$11000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $41000.0 in Q1 2016, with the low at -$60000.0 in Q4 2016.
- Historically, Exchange Rate Effect has averaged -$4055.6 across 5 years, with a median of $0.0 in 2019.
- The largest YoY upside for Exchange Rate Effect was 366.67% in 2020 against a maximum downside of 1000.0% in 2020.
- Neurogene's Exchange Rate Effect stood at -$60000.0 in 2016, then jumped by 90.0% to -$6000.0 in 2017, then plunged by 333.33% to -$26000.0 in 2018, then jumped by 103.85% to $1000.0 in 2019, then surged by 1300.0% to $14000.0 in 2020.
- The last three Exchange Rate Effect figures came in at $14000.0 (Q2 2020), -$11000.0 (Q1 2020), and $1000.0 (Q4 2019), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 8.68 Mn |
| 10 | Neurogene | 216.17 Mn | 216.17 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 14,000.00 |
| Jun 30, 2020 | 14,000.00 |
| Mar 31, 2020 | -11,000.00 |
| Mar 31, 2020 | -11,000.00 |
| Dec 31, 2019 | 1,000.00 |
| Dec 31, 2019 | 1,000.00 |
| Sep 30, 2019 | 7,000.00 |
| Sep 30, 2019 | 7,000.00 |
| Jun 30, 2019 | 3,000.00 |
| Jun 30, 2019 | 3,000.00 |
| Mar 31, 2019 | -1,000.00 |
| Mar 31, 2019 | -1,000.00 |
| Dec 31, 2018 | -26,000.00 |
| Dec 31, 2018 | -26,000.00 |
| Sep 30, 2018 | -3,000.00 |
| Sep 30, 2018 | -3,000.00 |
| Jun 30, 2018 | -27,000.00 |
| Jun 30, 2018 | -27,000.00 |
| Mar 31, 2018 | 8,000.00 |
| Mar 31, 2018 | 8,000.00 |